Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (10920)
All Articles published online
|
Publishing Process of This Article
|
Jan 28, 2016 (publication date) through Nov 22, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Yoon JC, Yang CM, Song Y, Lee JM. Natural killer cells in hepatitis C: Current progress. World J Gastroenterol 2016; 22(4): 1449-1460 [PMID: 26819513 DOI: 10.3748/wjg.v22.i4.1449] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v22/i4/1449.htm |
| Number | Citing Articles |
| 1 |
Hugo R. Rosen, Lucy Golden-Mason. Control of HCV Infection by Natural Killer Cells and Macrophages. Cold Spring Harbor Perspectives in Medicine 2020; 10(9): a037101 doi: 10.1101/cshperspect.a037101
|
| 2 |
M. Hentzien, A. Guihot, Doé de Maindreville, T. Tabary, V. Brodard, V. Vieillard, H. Adle-Biassette, F. Bani-Sadr. Progressive multifocal leukoencephalopathy despite immune recovery in a HIV/HCV co-infected patient. Journal of NeuroVirology 2020; 26(4): 607 doi: 10.1007/s13365-020-00848-x
|
| 3 |
Julia Pollmann, Alexander Rölle, Maike Hofmann, Adelheid Cerwenka. Hepatitis C Virus and Human Cytomegalovirus—Natural Killer Cell Subsets in Persistent Viral Infections. Frontiers in Immunology 2017; 8 doi: 10.3389/fimmu.2017.00566
|
| 4 |
Chao Zhang, Xiao-mei Wang, Shu-ran Li, Trix Twelkmeyer, Wei-hong Wang, Sheng-yuan Zhang, Shu-feng Wang, Ji-zheng Chen, Xia Jin, Yu-zhang Wu, Xin-wen Chen, Sheng-dian Wang, Jun-qi Niu, Hai-rong Chen, Hong Tang. NKG2A is a NK cell exhaustion checkpoint for HCV persistence. Nature Communications 2019; 10(1) doi: 10.1038/s41467-019-09212-y
|
| 5 |
Roberto Giulio Romanelli, Gianfranco Vitiello, Stefano Gitto, Maria Grazia Giudizi, Roberta Biagiotti, Alessia Carraresi, Francesco Vizzutti, Giacomo Laffi, Fabio Almerigogna. Characterization of lymphocyte subsets in ascitic fluid and peripheral blood of decompensated cirrhotic patients with chronic hepatitis C and alcoholic liver disease: A pivotal study. International Journal of Immunopathology and Pharmacology 2020; 34 doi: 10.1177/2058738420929587
|
| 6 |
C. Fernández‐Ponce, M. Dominguez‐Villar, J. P. Muñoz‐Miranda, M. M. Arbulo‐Echevarria, R. Litrán, E. Aguado, F. García‐Cozar. Immune modulation by the hepatitis C virus core protein. Journal of Viral Hepatitis 2017; 24(5): 350 doi: 10.1111/jvh.12675
|
| 7 |
Teresa Anita Mulaikal, Jean C. Emond. Liver Anesthesiology and Critical Care Medicine. 2018; : 3 doi: 10.1007/978-3-319-64298-7_1
|
| 8 |
Jose Ramón Vidal-Castiñeira, Antonio López-Vázquez, Paula Diaz-Bulnes, Susana Díaz-Coto, Leonardo Márquez-Kisinousky, Jesús Martínez-Borra, Carmen A. Navascues, Paloma Sanz-Cameno, Juan de la Vega, Aurora Astudillo, Manuel Rodríguez, Carlos López-Larrea. Genetic contribution of endoplasmic reticulum aminopeptidase 1 polymorphisms to liver fibrosis progression in patients with HCV infection. Journal of Molecular Medicine 2020; 98(9): 1245 doi: 10.1007/s00109-020-01948-1
|
| 9 |
Stephanie Jost, Jenny Ahn, Sarah Chen, Taylor Yoder, Kayitare Eunice Gikundiro, Esther Lee, Simon B Gressens, Kyle Kroll, Melissa Craemer, G Campbell Kaynor, Michelle Lifton, C Sabrina Tan. Upregulation of the NKG2D Ligand ULBP2 by JC Polyomavirus Infection Promotes Immune Recognition by Natural Killer Cells. The Journal of Infectious Diseases 2024; 229(6): 1836 doi: 10.1093/infdis/jiad424
|
| 10 |
V. V. Tsukanov, M. A. Cherepnin, A. A. Savchenko, A. V. Vasyutin, E. V. Kasparov, A. G. Borisov, V. D. Belenyuk, Ju. L. Tonkikh. Subpopulation composition of blood NK cells in patients with hepatitis C with genotype 1 or 3. Meditsinskiy sovet = Medical Council 2023; (18): 44 doi: 10.21518/ms2023-058
|
| 11 |
Sarah Vollmers, Annabelle Lobermeyer, Christian Körner. The New Kid on the Block: HLA-C, a Key Regulator of Natural Killer Cells in Viral Immunity. Cells 2021; 10(11): 3108 doi: 10.3390/cells10113108
|
| 12 |
Joshua D. Duncan, Richard A. Urbanowicz, Alexander W. Tarr, Jonathan K. Ball. Hepatitis C Virus Vaccine: Challenges and Prospects. Vaccines 2020; 8(1): 90 doi: 10.3390/vaccines8010090
|
| 13 |
Qingliang Wang, Xiaojie Li, Yaqiong Chen, Jiao Gong, Bo Hu. Classification and survival prediction in early‐stage cirrhosis by gene expression profiling. Journal of Viral Hepatitis 2023; 30(2): 116 doi: 10.1111/jvh.13769
|
| 14 |
Pil Soo Sung, Jeong Won Jang. Natural Killer Cell Dysfunction in Hepatocellular Carcinoma: Pathogenesis and Clinical Implications. International Journal of Molecular Sciences 2018; 19(11): 3648 doi: 10.3390/ijms19113648
|
| 15 |
Mengdi Qi, Mengmei Yang, Liangzi Xu, Chunli Ma, Pu Huang, Jing Sun, Jiandong Shi, Yunzhang Hu. Complete genome analysis identifies recombinant events and positive selection sites of hepatitis C virus from mainland China during 2010–2019. Virus Research 2021; 296: 198354 doi: 10.1016/j.virusres.2021.198354
|
| 16 |
Grace E. Cooper, Kristoffer Ostridge, Salim I. Khakoo, Tom M. A. Wilkinson, Karl J. Staples. Human CD49a+ Lung Natural Killer Cell Cytotoxicity in Response to Influenza A Virus. Frontiers in Immunology 2018; 9 doi: 10.3389/fimmu.2018.01671
|
| 17 |
Marc G. Ghany, Christopher M. Walker, Patrizia Farci. The Liver. 2020; : 868 doi: 10.1002/9781119436812.ch65
|
| 18 |
Madeline J. Lee, Catherine A. Blish. Defining the role of natural killer cells in COVID-19. Nature Immunology 2023; 24(10): 1628 doi: 10.1038/s41590-023-01560-8
|
| 19 |
Ali A. Rabaan, Shamsah H. Al-Ahmed, Ali M. Bazzi, Wadha A. Alfouzan, Shahab A. Alsuliman, Fatimah A. Aldrazi, Shafiul Haque. Overview of hepatitis C infection, molecular biology, and new treatment. Journal of Infection and Public Health 2020; 13(5): 773 doi: 10.1016/j.jiph.2019.11.015
|
| 20 |
Zepei Feng, Peng Huang, Jinwei Zhang, Xueshan Xia, A‐mei Zhang, Tian Zeng, Qiong Chen, Chuanlong Zhu, Weilong Tan, Yun Zhang, Ming Yue. KIR2DL4/HLA‐G polymorphisms were associated with HCV infection susceptibility among Chinese high‐risk population. Journal of Medical Virology 2023; 95(3) doi: 10.1002/jmv.28645
|
| 21 |
Chao Shen, Zhijun Ge, Chen Dong, Chunhui Wang, Jianguo Shao, Weihua Cai, Peng Huang, Haozhi Fan, Jun Li, Yun Zhang, Ming Yue. Genetic Variants in KIR/HLA-C Genes Are Associated With the Susceptibility to HCV Infection in a High-Risk Chinese Population. Frontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.632353
|
| 22 |
Ayesha Obaid, Anam Naz, Aqsa Ikram, Faryal Mehwish Awan, Abida Raza, Jamil Ahmad, Amjad Ali. Model of the adaptive immune response system against HCV infection reveals potential immunomodulatory agents for combination therapy. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-018-27163-0
|
| 23 |
Julián Piñeiro Fernández, Kimberly A. Luddy, Cathal Harmon, Cliona O’Farrelly. Hepatic Tumor Microenvironments and Effects on NK Cell Phenotype and Function. International Journal of Molecular Sciences 2019; 20(17): 4131 doi: 10.3390/ijms20174131
|
| 24 |
Elena Perpiñán, Sofía Pérez-Del-Pulgar, María-Carlota Londoño, Zoe Mariño, Concepción Bartres, Patricia González, Mireia García-López, Elisa Pose, Sabela Lens, Mala K. Maini, Xavier Forns, George Koutsoudakis. Cirrhosis Hampers Early and Rapid Normalization of Natural Killer Cell Phenotype and Function in Hepatitis C Patients Undergoing Interferon-Free Therapy. Frontiers in Immunology 2020; 11 doi: 10.3389/fimmu.2020.00129
|
| 25 |
Kamal Kajal, Venkata Ganesh, Sameer Sethi. Peri-operative Anesthetic Management in Liver Transplantation. 2023; : 15 doi: 10.1007/978-981-19-6045-1_2
|
| 26 |
Daniela Alejandra Rios, Paola Cecilia Casciato, María Soledad Caldirola, María Isabel Gaillard, Cecilia Giadans, Beatriz Ameigeiras, Elena Noemí De Matteo, María Victoria Preciado, Pamela Valva. Chronic Hepatitis C Pathogenesis: Immune Response in the Liver Microenvironment and Peripheral Compartment. Frontiers in Cellular and Infection Microbiology 2021; 11 doi: 10.3389/fcimb.2021.712105
|
| 27 |
Chang Mo Yang, Joo Chun Yoon, Jeon Han Park, Jae Myun Lee, Ranjit Ray. Hepatitis C virus impairs natural killer cell activity via viral serine protease NS3. PLOS ONE 2017; 12(4): e0175793 doi: 10.1371/journal.pone.0175793
|
| 28 |
Sergey M. Ivanov, Olga A. Tarasova, Vladimir V. Poroikov. Transcriptome-based analysis of human peripheral blood reveals regulators of immune response in different viral infections. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1199482
|
| 29 |
Vladislav Vladimirovich Tsukanov, Andrei Anatolyevich Savchenko, Mikhail Aleksandrovich Cherepnin, Eduard Vilyamovich Kasparov, Elena Petrovna Tikhonova, Alexander Viktorovich Vasyutin, Julia Leongardovna Tonkikh, Anna Alexandrovna Anisimova, Vasily Dmitrievich Belenyuk, Alexandr Gennadyevich Borisov. Association of Blood NK Cell Phenotype with the Severity of Liver Fibrosis in Patients with Chronic Viral Hepatitis C with Genotype 1 or 3. Diagnostics 2024; 14(5): 472 doi: 10.3390/diagnostics14050472
|
| 30 |
Joseph M. Cicchese, Stephanie Evans, Caitlin Hult, Louis R. Joslyn, Timothy Wessler, Jess A. Millar, Simeone Marino, Nicholas A. Cilfone, Joshua T. Mattila, Jennifer J. Linderman, Denise E. Kirschner. Dynamic balance of pro‐ and anti‐inflammatory signals controls disease and limits pathology. Immunological Reviews 2018; 285(1): 147 doi: 10.1111/imr.12671
|
| 31 |
Mena Al-Ani, Noha Mousaad Elemam, Jennifer Elisabeth Hundt, Azzam A Maghazachi. <p>Drugs for Multiple Sclerosis Activate Natural Killer Cells: Do They Protect Against COVID-19 Infection?</p>. Infection and Drug Resistance 2020; : 3243 doi: 10.2147/IDR.S269797
|
| 32 |
Gaitan Fabrice Njiomegnie, Scott A. Read, Nicole Fewings, Jacob George, Fiona McKay, Golo Ahlenstiel. Immunomodulation of the Natural Killer Cell Phenotype and Response during HCV Infection. Journal of Clinical Medicine 2020; 9(4): 1030 doi: 10.3390/jcm9041030
|
| 33 |
Evgeniya V. Shmeleva, Francesco Colucci. Maternal natural killer cells at the intersection between reproduction and mucosal immunity. Mucosal Immunology 2021; 14(5): 991 doi: 10.1038/s41385-020-00374-3
|
| 34 |
Julia Pollmann, Jana-Julia Götz, Daniel Rupp, Otto Strauss, Markus Granzin, Oliver Grünvogel, Pascal Mutz, Catharina Kramer, Felix Lasitschka, Volker Lohmann, Niklas K. Björkström, Robert Thimme, Ralf Bartenschlager, Adelheid Cerwenka. Hepatitis C virus-induced natural killer cell proliferation involves monocyte-derived cells and the OX40/OX40L axis. Journal of Hepatology 2018; 68(3): 421 doi: 10.1016/j.jhep.2017.10.021
|
| 35 |
Han-ji Jiang, Xiao-xiao Wang, Bi-fen Luo, Xu Cong, Qian Jin, Hong Qin, Hai-ying Zhang, Xiang-sha Kong, Lai Wei, Bo Feng. Direct antiviral agents upregulate natural killer cell potential activity in chronic hepatitis C patients. Clinical and Experimental Medicine 2019; 19(3): 299 doi: 10.1007/s10238-019-00564-9
|
| 36 |
Abdollah Jafarzadeh, Alma Naseri, Layla Shojaie, Maryam Nemati, Sara Jafarzadeh, Hossein Bannazadeh Baghi, Michael R Hamblin, Seyed Amirreza Akhlagh, Hamed Mirzaei. MicroRNA-155 and antiviral immune responses. International Immunopharmacology 2021; 101: 108188 doi: 10.1016/j.intimp.2021.108188
|
| 37 |
Dora Maria Popescu, Dorin Nicolae Gheorghe, Flavia Nicolae, Lucian Paul Dragomir, Allma Pitru, Andrada Soanca, Cristina Florescu, Vasilica Toma, Liliana Georgeta Foia, Alexandra Livia Roman, Petra Surlin, Ion Rogoveanu. Chemokines Updates. Biochemistry 2023; 40 doi: 10.5772/intechopen.107318
|